| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5955109 | BAUSCH | Methods and compositions for topical delivery of retinoic acid |
Sep, 2016
(7 years ago) | |
Retin-A Micro is owned by Bausch.
Retin-A Micro contains Tretinoin.
Retin-A Micro has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Retin-A Micro are:
- US5955109
Retin-A Micro was authorised for market use on 10 May, 2002.
Retin-A Micro is available in gel;topical dosage forms.
Retin-A Micro can be used as treatment of acne vulgaris.
The generics of Retin-A Micro are possible to be released after 21 September, 2016.
Drugs and Companies using TRETINOIN ingredient
Market Authorisation Date: 10 May, 2002
Treatment: Treatment of acne vulgaris
Dosage: GEL;TOPICAL
How can I launch a generic of RETIN-A MICRO before it's drug patent expiration?
More Information on Dosage
RETIN-A MICRO family patents
